RecruitingPhase 3NCT07208058
4
studies recruiting now
as of 7 Sept 2026
28
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
14 May 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT07588295
Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease
RecruitingNCT06339177
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
RecruitingNCT07312474
Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Macrophage activation syndrome studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Macrophage activation syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Macrophage activation syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
4 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Methylprednisolone (Medrol)
Phase 3Ruxolitinib (Jakavi)
Phase 2Anakinra (Antril)
Phase 1/2Aldesleukin (Proleukin)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).